logo
This prescription hair loss gummy is made in pharmacy — and was specifically designed for women

This prescription hair loss gummy is made in pharmacy — and was specifically designed for women

New York Post5 hours ago

It might be a man's world, but women are losing their locks too.
Now there's a sweet way to fight back: Telehealth company Hims & Hers just launched the first-ever clinically proven prescription hair growth gummy made specifically for women battling chronic hair loss, and they promise they've got the FDA to back up what's in their supplement.
The Post spoke with Dr. Jessica Shepherd, the company's chief medical officer, to get the lowdown on the brand-new Biotin + Minoxidil Gummy — and why female hair loss is finally getting a moment in the spotlight.
Advertisement
5 Hers' Biotin + Minoxidil Gummy combines two hair loving ingredients to support your strands.
HERS
More than a bad hair day
Shedding 50 to 100 strands per day is generally considered normal — but for many, hair loss goes way beyond that.
By age 50, about 85% of men and 40% of women experience noticeably thinning hair, according to the American Hair Loss Association.
'Female hair loss usually appears as overall thinning across the scalp, whereas male hair loss typically involves more defined patterns such as a receding hairline or bald spots,' Shepherd told The Post.
Advertisement
And it's not just grandma's problem. Studies show that 12% of women start losing their hair before they reach 30.
Despite the widespread experience, Shepherd said the healthcare industry has historically focused on the source of male-pattern baldness.
'This leaves conditions unique to women, such as polycystic ovarian syndrome, menopause and postpartum hair loss, largely underexplored and misunderstood,' she explained. 'As a result, many women feel unheard and unseen, with their concerns dismissed.'
Advertisement
5 Hair loss in women is often treatable, especially when addressed early.
Nadya Kolobova – stock.adobe.com
To make matters worse, Shepherd said the link between hair health and overall wellbeing — especially factors like inflammation, stress, nutrition deficiencies and hormone imbalances — often gets ignored, preventing women from getting the full care they need.
'We understand these specific challenges women face and proactively consider how we can make access to quality treatment seamless and convenient,' she said.
A gummy game-changer
Advertisement
Minoxidil — commonly sold under the brand name Rogaine — is the only FDA-approved drug to treat both male and female pattern hair loss. But Shepherd said dosage and application varies due to hormonal and physiological differences between the sexes.
That's where Hers' new gummy comes in.
5 The Biotin + Minoxidil gummy is prescription strength.
HERS
Green apple flavored and prescription-only, it's the first dermatologist-formulated gummy made specifically for women's chronic hair loss. It combines minoxidil for density with biotin for fullness — a double dose of clinically backed hair help.
'Licensed medical providers on the Hers platform can work with you to find the best plan for your hair, including prescribing personalized treatments with clinically proven ingredients based on your needs,' Shepherd said.
And unlike messy foams or tough-to-swallow pills, this gummy is designed to be a treat — not a chore.
'The truth is, it doesn't matter how well a medication works if it's not taken consistently,' Shepherd said. 'Our mission was to help women foster adherence through genuine desire, not forced routine.'
Advertisement
But not all gummies are created equal — in fact, many have been criticized for nutrient inconsistencies and lack of oversight.
Shepherd said Hers guarantees quality by manufacturing their gummies in an FDA-regulated pharmacy that follows strict US Pharmacopeia standards.
5 Minoxidil is an ingredient proven to regrow hair in 3-6 months.
HERS
But does hair grow… everywhere?
Minoxidil — whether oral or topical — can sometimes cause unwanted hair growth in places beyond your scalp. The gummy might have the same side effect.
Advertisement
'While we know this isn't ideal, shaving, plucking, or waxing should do the trick,' Shepherd said.
'A provider through Hers will review potential side effects with you, address any questions you might have, and provide guidance tailored to your health profile,' she added.
More than just hair
Hair loss treatments do more than boost your strand count.
Advertisement
'When a woman experiences hair loss, the emotional toll can be significant,' Shepherd said. 'They may feel shame, loneliness or isolation and hesitate sharing their struggles, even with loved ones.'
One study found that 52% of women feel extreme distress over hair loss — nearly double the 27% of men who said the same.
5 Hair is often deeply intertwined with a woman's sense of self and femininity.
blackday – stock.adobe.com
Advertisement
The study also showed 53% of women feel less physically attractive and 65% less sexy, compared to just 35% of men.
'We're actively addressing these emotional aspects by fostering a compassionate, supportive community and making these conditions more approachable and treatments more accessible to affirm every woman's unique concerns as valid and important,' Shepherd said.
'We all deserve the ability to feel our best — how we feel inside in turns how we can show up for others, but more importantly, for ourselves,' she continued.
Beyond the surface
No matter your gender, Shepherd said 'healthy hair begins on the inside.'
To prevent thinning and keep hair thick, she recommends a proactive, holistic approach. That means starting before your strands fall out.
'In addition to the right hair care routine using gentle, nourishing products to support a healthy scalp, lifestyle, stress and nutrition are also critical,' Shepherd said.
'Managing stress levels through lifestyle changes like sleep and exercise, and a nutrient-rich diet with enough protein, healthy fats, and vitamins, are crucial to maintaining a healthy head of hair,' she added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More Adults Can Now Get Moderna's RSV Shot
More Adults Can Now Get Moderna's RSV Shot

WebMD

timean hour ago

  • WebMD

More Adults Can Now Get Moderna's RSV Shot

June 17, 2025 – The FDA has expanded the use of Moderna's respiratory syncytial virus (RSV) shot to all adults, with some limits on who can get it. First approved in 2024 for people 60 or older, the mRESVIA vaccine protects against lower respiratory infections caused by RSV. This vaccine is now approved for adults ages 18 to 59 who have a higher risk of getting a serious RSV illness. RSV is a common virus that spreads easily in colder months through coughs, sneezes, or contact with contaminated surfaces. While it usually causes mild cold-like symptoms, it can be serious for babies and older adults. Vaccines and other preventive treatments offer the best protection against RSV. Moderna said the approval was supported by a study showing the vaccine is safe and works well for younger adults (ages 18 to 59) with medical conditions. Their immune response was just as strong as in older adults (60+), who had been studied earlier. All younger adults produced similar levels of protective antibodies against the two main types of RSV (RSV-A and RSV-B), showing the vaccine works well across at-risk adults of different ages. mRESVIA is an RNA vaccine that trains the body to make a harmless version of a protein used by the respiratory syncytial virus to enter human cells. This helps the immune system recognize the virus and build antibodies to protect against future infections. The vaccine does not contain RSV, so it cannot cause RSV illness. In clinical trials, the shot was generally well-tolerated. The most common side effects were mild and included pain where the needle went in, tiredness, headaches, muscle aches, joint pain, chills, nausea or vomiting, fever, and hives. Moderna plans to make mRESVIA available in the U.S. for the 2025-2026 respiratory virus season for high-risk adults ages 18 to 59 and all adults age 60 or older. Patients should tell their health care provider about any medical conditions they may have before getting the vaccine. This includes allergies, any serious reactions to vaccines in the past, current fever, any bleeding disorder or use of blood thinners, and a weakened immune system or use of medications that affect it. Patients should also say if they've already received another RSV vaccine or if they've ever fainted after getting a shot. There is a very small chance that mRESVIA can cause a severe allergic reaction, so patients may be asked to stay a while for observation after the shot.

How MAHA and AI can transform public health
How MAHA and AI can transform public health

Fast Company

time3 hours ago

  • Fast Company

How MAHA and AI can transform public health

The Make America Healthy Again (MAHA) movement represents a transformative opportunity to reshape the landscape of public health in the United States. With chronic disease now widely recognized as a pressing public health crisis, there is an urgent need for innovative solutions that go beyond traditional approaches. The MAHA Commission has set the stage for a new era in health policy, and artificial intelligence can serve as a pivotal force in accelerating its impact. By integrating AI and centralized health data, MAHA can drive meaningful progress in nutrition and metabolic health, offering personalized and scientifically-backed solutions to combat chronic disease. Recent developments surrounding the regulation of synthetic food dyes signal a major milestone in American health policy. We are witnessing the first serious crack in the armor of the U.S. food industry. For decades, tens of millions of Americans have unknowingly consumed potentially harmful chemicals such as Yellow 5 and Red 40, dyes already restricted in Europe. The FDA's decision to phase out these additives represents a meaningful shift toward a safer, more transparent food system. This is a critical and positive step forward: Food should nourish, not harm. As someone deeply committed to advancing health outcomes, I view this as a welcome and necessary correction. Don't politicize health While MAHA and U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. (RFK) have drawn both support and criticism, my focus remains clear: How do we improve health? On that front, I support any movement taking tangible steps to make our food supply healthier and more accountable. Historically, public health recommendations have been one-size-fits-all, often failing to address the individual metabolic and lifestyle factors that shape personal health outcomes. MAHA has the potential to change this paradigm by embracing AI-driven personalized medicine. AI can analyze vast datasets spanning dietary habits, genetic predispositions, and environmental exposures to generate tailored health recommendations that empower individuals to make optimal nutritional choices. I am opposed to the politicization of American health. It disproportionately harms the most vulnerable, particularly low-income communities, who already face significant barriers to accessing nutritious food. My focus is metabolic health, and our most urgent challenge is what's on our plates. The fact that more than 10,000 chemicals are permitted in the U.S. food supply, while only about 400 are allowed in Europe, is indefensible. This is not just a regulatory gap; it is a public health failure that must be addressed. No one has successfully challenged the U.S. food industry until now. Some states are proposing or adopting changes aligned with MAHA such as soda bans, dye eliminations, and ultra-processed food limits in schools, and some corporations like PepsiCo are eliminating food dyes from its products. Over half of U.S. states are introducing legislation to address synthetic dyes. With MAHA's clear intentions, any company that wants its food served in America's largest restaurant chain (i.e. American school cafeterias), is asking themselves how they can realistically get dyes out of their foods. AI can help It is now widely acknowledged that diet plays a fundamental role in chronic conditions such as diabetes, cardiovascular disease, and obesity, which affect 133 million Americans. Despite this awareness, progress in addressing these issues has been slow. In addition to the important steps of improving school lunches and banning potentially harmful chemicals from foods, AI-powered tools can also be incorporated into preventive care in programs like Medicare wellness visits, SNAP (Supplemental Nutrition Assistance Program), school health education, and veteran services. AI tools can provide real-time insights into the metabolic effects of foods before consumption, enabling individuals to make healthier choices based on their unique health profiles. They can also create highly personalized plans and virtual coaches to help individuals reach their health goals. For AI to fulfill its potential, it must be fueled by centralized, comprehensive health data. A unified data repository that aggregates nutritional information, health metrics, and environmental factors across diverse communities is essential. This centralized approach enhances the accuracy and responsiveness of AI algorithms, ensuring that health recommendations evolve in tandem with emerging scientific research. Realizing this vision will require close collaboration between government agencies, private-sector innovators, and healthcare and technology experts. The White House Office of Science and Technology Policy, especially under leaders like Michael Kratsios, can partner with Silicon Valley's AI leaders to set new standards for data-driven health policy. Together, we can ensure AI-driven insights are accessible to all Americans. We are living through a rare window of possibility. As RFK Jr. and MAHA work to improve our food system and as AI becomes a force multiplier for health equity, we have the tools to take real action. The removal of food dyes is only the beginning. The real test for all of us, including MAHA, is whether we can also address the larger crises of ultra-processed food, excess sugar, and nutritional inequality. The future of public health depends not on ideological battles, but on constructive action. Let's focus on what matters: addressing the root cause, rather than just treating chronic disease, and improving the health span of all Americans.

Couple lied about cancer-detecting machine, then sold fake cure, feds say
Couple lied about cancer-detecting machine, then sold fake cure, feds say

Miami Herald

time4 hours ago

  • Miami Herald

Couple lied about cancer-detecting machine, then sold fake cure, feds say

A third person has been charged after authorities say they lied to patients about being able to detect and cure cancer. Mary Blakley and Fred Blakley were each charged in January with several counts of mail fraud, wire fraud and conspiracy to violate the Food, Drug and Cosmetic Act. In a superseding indictment filed June 5, Janmarie Lanzo was charged with conspiracy to violate the Food, Drug and Cosmetic Act and defraud the Food and Drug Administration, according to court records and a June 17 news release from the U.S. Attorney's Office for the Eastern District of Pennsylvania. McClatchy News reached out to attorneys for Mary Blakley, Fred Blakley and Janmarie Lanzo but did not immediately hear back. Mary Blakley and Fred Blakley are accused of running a medical clinic business where they charged patients across the U.S. for 'full body scans,' according to prosecutors. Lanzo was a business associate who worked at the clinics and sold products to patients, officials said. Mary Blakley and Fred Blakley typically charged patients $300 for a scan by an ultrasound machine, officials said. They told the patients that Mary Blakley invented a 'smart chip technology' that when added to the ultrasound machine, could detect 'a wide variety of human diseases and medical conditions, including cancers,' prosecutors said. The couple and their employees told patients that this technology could 'treat and cure a wide range of human diseases, illnesses and conditions, including by: 'driving' a substance known as Aetheion into the body to kill cancer,' the indictment said. 'Based on the results of these 'full body scans,' the defendants falsely and fraudulently prescribed to their human clients various supplements, creams, and veterinary products,' officials said. The three sold Aetheion, a cosmetic cream, to patients, according to the release. They also sold them fenbendazole, a veterinary antiparasitic, and told them it could treat cancer, officials said. Fenbendazole is not approved for human use by the FDA, court records said. It is typically used to treat worms in animals. The three also prescribed ProArgi9+ and told patients it was used to treat multiple sclerosis and diabetes, court records said. ProArgi9+ is not approved by the FDA to treat diseases and is used as a dietary supplement. Mary Blakley carried out the scheme by lying about having a Ph.D. in radiation nuclear physics, having dual U.S./Swedish citizenship and working as a cancer specialist and part of a research team that developed fenbendazole, according to court records. If convicted, Mary Blakley and Fred Blakley face 165 years in prison and Lanzo faces five years in prison.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store